Related Experiment Video
Updated: Oct 20, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
MKP-1 Overexpression Reduces Postischemic Myocardial Damage through Attenuation of ER Stress and Mitochondrial Damage
Xiaoling Hou1, Lijun Li1, Si Chen2
1Senior Department of Cardiology, The Sixth Medical Center of People's Liberation Army General Hospital, Beijing, China.
Abstract:
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress contribute to postischemic myocardial damage, but the upstream regulatory mechanisms have not been identified. In this study, we analyzed the role of mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) in the regulation of mitochondrial function and ER stress in hypoxic cardiomyocytes. Our results show that MKP-1 overexpression sustains viability and reduces hypoxia-induced apoptosis among H9C2 cardiomyocytes. MKP-1 overexpression attenuates ER stress and expression of ER stress genes and improves mitochondrial function in hypoxia-treated H9C2 cells. MKP-1 overexpression also increases ATP production and mitochondrial respiration and attenuates mitochondrial oxidative damage in hypoxic cardiomyocytes. Moreover, our results demonstrate that ERK and JNK are the downstream signaling targets of MKP-1 and that MKP-1 overexpression activates ERK, while it inhibits JNK. Inhibition of ERK reduces the ability of MKP-1 to preserve mitochondrial function and ER homeostasis in hypoxic cardiomyocytes. These results show that MKP-1 plays an essential role in the regulation of mitochondrial function and ER stress in hypoxic H9C2 cardiomyocytes through normalization of the ERK pathway and suggest that MKP-1 may serve as a novel target for the treatment of postischemic myocardial injury.
Insights
Mitogen-activated protein kinase phosphatase 1 (MKP-1) protects heart cells from damage after oxygen deprivation. Overexpressing MKP-1 improves mitochondrial function and reduces endoplasmic reticulum stress, suggesting it as a therapeutic target for heart injury.
Area of Science:
- Cardiovascular Biology
- Cellular Stress Response
- Mitochondrial Medicine
Background:
- Mitochondrial dysfunction and endoplasmic reticulum (ER) stress are key factors in post-ischemic myocardial injury.
- The upstream regulators of these processes remain largely unidentified.
Purpose of the Study:
- To investigate the role of mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) in regulating mitochondrial function and ER stress in hypoxic cardiomyocytes.
- To explore MKP-1 as a potential therapeutic target for post-ischemic myocardial damage.
Main Methods:
- Overexpression of MKP-1 in H9C2 cardiomyocytes under hypoxic conditions.
- Assessment of cell viability, apoptosis, ER stress markers, mitochondrial function (ATP production, respiration), and oxidative damage.
- Analysis of downstream signaling pathways, specifically ERK and JNK.
Main Results:
- MKP-1 overexpression significantly enhanced H9C2 cell viability and reduced hypoxia-induced apoptosis.
- MKP-1 attenuated ER stress, decreased ER stress gene expression, and improved mitochondrial function, including increased ATP production and respiration.
- MKP-1 activated ERK signaling while inhibiting JNK signaling; ERK inhibition compromised MKP-1's protective effects.
Conclusions:
- MKP-1 plays a critical role in maintaining mitochondrial function and ER homeostasis in hypoxic cardiomyocytes.
- MKP-1 exerts its protective effects primarily through the activation of the ERK pathway.
- MKP-1 represents a promising novel therapeutic target for mitigating post-ischemic myocardial injury.
